Funding for this research was provided by:
National Institute on Drug Abuse (K23DA048162)
National Institute on Drug Abuse (R25DA037190)
National Center for Advancing Translational Sciences (U54TR001629)
National Center for Advancing Translational Sciences (UL1 TR003107)
Received: 23 February 2022
Accepted: 9 September 2022
First Online: 1 October 2022
: Review and approval was completed by the Institutional Review Board at the University of Arkansas for Medical Sciences under protocol 229172. All participants will complete the informed consent procedures approved by the overseeing Institutional Review Board prior to participation.
: Not applicable.
: The author(s) declare that they have no known competing interests that could have appeared to influence the work reported in this paper.